SUMMARY The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC) collected interview and medical information relating to the child's past medical experiences from parents of 555 children diagnosed with cancer and parents of 1110 unaffected matched controls. No significant associations emerged overall for ante-natal care, place and mode ofdelivery, length ofgestation, birth weight, condition at birth, special care, neonatal procedures or breast-feeding. Few risk factors relating to previous illnesses and medication were found, although increasing numbers of illnesses appeared to be associated with an increased risk of childhood cancer, particularly acute lymphoblastic leukaemia. A highly significant excess of case children had not been immunised (p = 0 005). In general, these results indicate that past medical experiences have little influence on the development of cancer in children.
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No major aetiological factors have been implicated in the development of childhood cancer. Because of the early onset and embryonal nature of most childhood tumours, investigations have focussed on the antenatal period as the time when any extrinsic factors, eg chemical exposures, may be effective in initiating tumour formation in the developing foetus. Indeed some degree of risk has been demonstrated for exposure to X-irradiation in pregnancy' 2 and reports have suggested transplacental carcinogenesis caused by drugs taken during pregnancy. 35 Other studies have implicated certain parental occupations in the development of childhood cancer but evidence on this is conflicting. 6 Indications of an important role for genetic factors in the aetiology of childhood cancer have been accumulating7 but the presence of genetic susceptibility does not necessarily imply that a child will develop cancer, and additional environmental factors may be needed to induce malignancy in a particular individual.
Some associations between post-natal medical events and specific types of childhood cancer have been demonstrated. For example Burkitt's lymphoma develops under special circumstances after infection with Epstein-Barr virus.8 A case-control study of children with leukaemia showed a lower frequency of infections among cases in the first year of life9 and tonsillectomy has been reported as a risk factor for Hodgkin's disease. ' Medical confirmation of the index child's malformations, serious and chronic illness and longterm medication was sought from general practitioner and hospital records. The mother's obstetric notes for the relevant pregnancy were routinely obtained.
Up to six illnesses in the index child were coded using the International Classification of Diseases (ICD9).12 Common named infectious diseases of childhood, ie chickenpox, measles, rubella, mumps and scarlet fever, were not coded unless they occurred under 6 Breast-feeding was thought unlikely to be a risk factor for children diagnosed with their tumour under 3 months of age and these children were eliminated from the analysis. Of the remaining 528 cases and their controls, fewer than half (44%) had been breast-fed and there was no evidence that breast-feeding conferred any protection against developing childhood cancer. There was some evidence that for all cases combined increasing numbers of reported illnesses over the age A L Hartley, J M Birch, P A McKinney, et al of 6 months were associated with an increased risk of childhood cancer. This effect was particularly apparent for children with ALL, and a more detailed analysis of this association is presented elsewhere. '9 In spite of extensive comparisons of illness groups and individual illnesses by diagnostic group within IRESCC (potentially over 10 000 comparisons were possible, although small numbers precluded more than about 200 calculations being carried out) no systematic pattern of risk factors in the child's past history of illness has emerged. Indeed very few significant results involving more than a tiny proportion of cases in each group were found (and at least as many such results as were observed would be expected by chance), and for some diagnostic groups no risk factors at all emerged.
The excess of illnesses over 6 months of age among the cases is explained by the highly significant case excess reporting symptoms, signs and ill-defined conditions (ICD9 780-799). Detailed examination showed that no individual diagnostic group had a significant excess of non-specific conditions. The excess was not related to age at onset and affected children with solid tumours and leukaemia equally. child with ALL and congenital cytomegalovirus infection also had a balanced chromosome translocation and that another child with Down's syndrome and ALL also had the same infection. Similarly because of the coding conventions adopted and the need for some simplification of the data, short courses of drugs given after the first month of life were not coded. Hence the overall significance of the use of chloramphenicol in IRESCC children cannot be assessed in the light of a recent report that there is a significantly elevated risk of ALL in children treated with chloramphenical for infectious disorders.24 However, two of the three children in IRESCC who had had bacterial meningitis had been treated with chloramphenicol. Both these children had ALL.
The overwhelming impression from the results presented here is of a lack of association between medical events in childhood and the subsequent development of childhood cancer. A very large number ofcomparisons were made, but few significant associations emerged and it is likely that some of these were due to chance. Where significant relative risks did emerge these were often restricted to specific diagnostic groups and although the study included a large number of cases overall, numbers in some diagnostic groups were quite small. Hence few findings could be applied to the generality of childhood cancer. The most important finding could be the apparent protective effect of immunisation. More detailed analyses of the results by diagnostic group may reveal more specific aetiological agents. Alternatively, the findings may show that environmental factors of the kind which we examined are lacking major aetiological importance. Genetic predisposition may have greater influence, or specific genetic-environmental interactions in certain children may not be detected by the present analysis. Further multi-variate analyses taking into account family history of malignancy and other factors, possibly prenatal, would be necessary to throw light on these issues.
